1. djmanicmusic
2. seam23
3. mrwhite14
4. kaalm
5. heppnerda
1.seam23 03/29/2018
Shares under pressure on news of Pfizer approval and potential competition for patisiran
2.seam23 01/25/2018
Leerink Partners raises PT to $135 from $132
3.mrwhite14 06/04/2018
FDA has granted Orphan Drug Designation to ALN-TTRsc02
4.djmanicmusic 07/27/2018
CHMP has adopted a Positive Opinion recommending marketing authorization of patisiran
5.djmanicmusic 05/03/2018
Finally reached alignment with the FDA on a pivotal study design for lumasiran
6.seam23 02/08/2018
Beats EPS loss estimates by $0.19 and beats on revenues
7.mrwhite14 02/09/2018
Morgan Stanley
8.mrwhite14 04/16/2018
Alnylam Presents New Positive Clinical Results for Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias
9.mrwhite14 03/26/2018
These 12 Drugs Launching In 2018 Are Headed For Blockbuster Status
10.djmanicmusic 04/20/2018
Dicerna Pharmaceuticals has resolved all litigation with Alnylam Pharmaceuticals
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW